trending Market Intelligence /marketintelligence/en/news-insights/trending/lzG9eCEt04zLgRdpRVrePA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

FSD Pharma receives approval to list on Nasdaq

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


FSD Pharma receives approval to list on Nasdaq

FSD Pharma Inc. received approval to list its shares on the Nasdaq Capital Market.

The Cobourg, Ontario-based company will have its class B subordinate voting shares, a type of common stock, listed on Nasdaq. Trading of the stocks will start in the near future, the company said, without giving a date.

FSD Pharma is already listed on the Canadian Securities Exchange. The company in October said it is consolidating its class A multiple voting shares and its class B subordinate voting shares, each on a 1-to-201 basis. Following consolidation, FSD Pharma will have 72 issued and outstanding class A shares, representing 276,660 votes or about 72% of the company's voting rights.

FSD Pharma is a medical cannabis company focused on developing indoor-grown pharmaceutical-grade cannabis.